1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
REPORT OVERVIEW
- This report offers market size & forecast data for the European vaccine packaging market. The revenue generated from the sale of vaccine packaging materials and products are included in the report. Revenue generated by service providers are excluded from the scope of the report. This report provides a comprehensive and current market scenario of Europe vaccine packaging, including the market size, anticipated market forecast, relevant market segmentations, and industry trends.
- The study considers a detailed scenario of the present vaccine packaging market and its market dynamics for 2023−2028 in Europe. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent players operating in the market.
MARKET DEFINITION
Vaccine packaging is the process that includes securely packaging vaccines to keep their therapeutic potency for a certain period. Vaccine packaging comprises vials, ampoules, prefilled syringes, and bags & pouches, which is the initial level of packaging.KEY HIGHLIGHTS
- The Europe vaccine packaging market was valued at $1,016.62 million in 2022 and is projected to reach $1,487.42 million in 2028, with a compound annual growth rate (CAGR) of 6.55%, during the study period.
- In 2022, the EU5 dominated the vaccine packaging market with the highest revenue share of 53.76%, followed by Central and Eastern Europe with 35.37% and then Nordic countries with 10.87%.
- The vaccine packaging market in Europe is witnessing significant growth due to increasing research and development (R&D) activities owing to the prevalence of various infectious diseases, the presence of leading vaccine players, well-developed infrastructure, high investments in drug development, and growing government initiatives.
- Primary Packaging accounted for the highest share of more than 71% in Europe's vaccine packaging market due to the growing demand for vials, ampoules, and syringes with the increasing vaccine demand.
- Based on primary packaging type, the vials packaging segment accounted for a 38.18% market share in the Europe vaccine packaging market. It dominated the other segments due to its wide usage as an essential primary packaging element for vaccine products.
- Based on material type, the glass segment accounts for a 44.09% Europe vaccine packaging market share attributed to its external barrier properties and its highest demand in primary packaging.
- The pharmaceutical and biotech companies accounted for the highest share of more than 46% in the Europe vaccine packaging market, which is owing to the rise in contagious or infectious diseases, the growing aging population, the growing demand for vaccines, innovations in vaccine development are some of the major factors driving the vaccine packaging industry.
- SCHOTT, Gerresheimer AG, Stevanato Group, Amcor, SGD Pharma, WestRock, Corning Incorporation, and Others are the leading players in the Europe vaccine Packaging market. The market offers tremendous growth opportunities for existing and future/emerging players because of innovations in oncology, infectious diseases, autoimmune, chronic ailments, and rare diseases.
VENDOR ANALYSIS
- SCHOTT Pharma
- Gerresheimers AG
- Stevanato Group
- SGD Pharma
- WestRock Pharma
- Amcor
- Aptar Group
- Corning International
- Catalent
- Becton, Dickinson and company (BD)
- Panasonic Health Corporation
- Cognex
- Airnov
- Bilcare Research
- DHL
- Borosil
- CCL
- Drug Plastics Group
- DWK Life Sciences
- LOG
- Eppendorf
- Renolit
- Qorpak
- Nipro
- Medical Packaging LLC
REPORT HIGHLIGHTS
1) PRODUCT SEGMENTATION & FORECAST
- Packaging level
- Primary
- Secondary
- Tertiary
- Packaging type
- Vials
- Ampoules
- Syringes
- Others
- Material type
- Glass
- Plastic
- Others
- End-user type
- Pharmaceuticals & Biotech Companies
- Healthcare Facilities
- Others
2) MARKET STRUCTURE
- Market Dynamics
- Competitive Landscape of the Vaccine Packaging Market
- Key Vendors
- Other Prominent Vendors
3) APPENDIX
- Research Methodology
- Abbreviations
- About Arizton
Table of Contents
CHAPTER - 1: Vaccine Packaging Market Overview
CHAPTER - 2: Vaccine Packaging Market
CHAPTER - 3: Vaccine Packaging Market Segmentation Data
CHAPTER - 4: Key Countries Overview
Central & Eastern Europe: Projected Revenue ($ MN; 2022-2028)
Nordic Countries: Projected Revenue ($ MN; 2022-2028)
CHAPTER - 5: Vaccine Packaging Market Prospects & Opportunities
CHAPTER - 6: Vaccine Packaging Industry Overview
CHAPTER - 7: Appendix
Companies Mentioned
- SCHOTT Pharma
- Gerresheimers AG
- Stevanato Group
- SGD Pharma
- WestRock Pharma
- Amcor
- Aptar Group
- Corning International
- Catalent
- Becton, Dickinson and company (BD)
- Panasonic Health Corporation
- Cognex
- Airnov
- Bilcare Research
- DHL
- Borosil
- CCL
- Drug Plastics Group
- DWK Life Sciences
- LOG
- Eppendorf
- Renolit
- Qorpak
- Nipro
- Medical Packaging LLC
Methodology
Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.
Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.
LOADING...
